Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What is a key aspect of the IRB/IEC continuing review process?

Continuing review is about maintaining ongoing protection for participants by periodically re-evaluating risk, safety data, consent, and protocol compliance as the study progresses. The timing of this review is guided by how risky the study is: higher-risk studies may need more frequent oversight, while lower-risk ones can be reviewed less often, but always on intervals that reflect the level of risk rather than a fixed timetable. This approach helps catch new safety concerns, unexpected adverse events, or protocol changes early. A one-time review wouldn’t provide ongoing oversight, fixed six-month intervals regardless of risk ignore the risk-based approach, and review timing isn’t determined by sponsor requests.

Continuing review is about maintaining ongoing protection for participants by periodically re-evaluating risk, safety data, consent, and protocol compliance as the study progresses. The timing of this review is guided by how risky the study is: higher-risk studies may need more frequent oversight, while lower-risk ones can be reviewed less often, but always on intervals that reflect the level of risk rather than a fixed timetable. This approach helps catch new safety concerns, unexpected adverse events, or protocol changes early. A one-time review wouldn’t provide ongoing oversight, fixed six-month intervals regardless of risk ignore the risk-based approach, and review timing isn’t determined by sponsor requests.